チエノピリミジン化合物の塩酸塩の結晶形 - Hammi Pharmaceuticals Company Limited

Title:

チエノピリミジン化合物の塩酸塩の結晶形

Document Type and Number:

Japanese Patent JP6907439

Kind Code:

B2

Abstract:

The present invention relates to a crystalline form of a hydrochloride salt of N-(3-(2-(4-(4-methylpiperazin-1-yl)phenylamino)thieno[3,2-d]pyrimidin-4-yloxy)phenyl)acrylamide, and a pharmaceutical composition containing the same. The crystalline form of the hydrochloride salt of the compound can be easily used for preparing a pharmaceutical composition containing the same as an active ingredient.

More Like This:

JP5647121	Indacenodithiophene and indacenodicerenovene Polymers and their use as organic semiconductors
WO/2011/156464	CRYSTALLINE FORMS OF KINASE INHIBITORS
JP2011251976	PIPERAZINYL-SUBSTITUTED PYRIDYLALKANE, ALKENE AND ALKINE CARBOXAMIDE

Inventors:

Beck, Jung Wook
Chung, Ji Young
Oh, hisk
Kim, hi chul
Chan, Song Young
Ha, tehi

Application Number:

JP2018533930A

Publication Date:

July 21, 2021

Filing Date:

December 30, 2016

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Hammi Pharmaceuticals Company Limited

International Classes:

C07D495/04; A61K31/519; A61P35/00; A61P43/00

Domestic Patent References:

JP2013529630A

Other References:

医薬品結晶の分子状態に関する物性評価(12) 塩・結晶形の最適化と結晶化技術,Pharm Tech Japan,2002年,vol.18, no.10,pp.81-96,ISSN 0910-4739
プロセス化学第2版医薬品合成から製造まで,2014年 3月30日,p.405-413,420-429,446-451
C.G.WERMUTH編,最新創薬化学下巻,株式会社テクノミック,1999年,p.347-365
平山令明,有機化合物結晶作製ハンドブック,2008年 7月25日,p.17-23,37-40,45-51,57-65

Attorney, Agent or Firm:

Atsushi Nakajima
Kato Kazunori

Previous Patent: 吸収式熱交換システム

Next Patent: 新規な化合物およびこれを用いた有機発光素子